Partitioning of cancer therapeutics in nuclear condensates
Harvard University · Dana-Farber Cancer Institute · +10 more institutions
Abstract
The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was also observed in tumor cells, where drug partitioning influenced drug activity. Altering the properties of the condensate was found to affect the concentration and activity of drugs. These results suggest that selective…
Citation impact
- FWCI
- 23.92
- Percentile
- 100%
- References
- 70
Authors
32- IAIsaac A. KleinCorresponding
Harvard University, Dana-Farber Cancer Institute, Whitehead Institute for Biomedical Research
- ABAnn BoijaCorresponding
Whitehead Institute for Biomedical Research
- LKLena K. Afeyan
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- SWSusana Wilson Hawken
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- MFMengyang Fan
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
- Cancer
- Computer science
- Computational biology
- Medicine
- Biology
- Internal medicine
- Good health and well-being